Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Methods Mol Biol. 2013;931:187–212. doi: 10.1007/978-1-62703-056-4_11

Laser Scanning Cytometry: Principles and Applications—An Update

Piotr Pozarowski, Elena Holden, Zbigniew Darzynkiewicz
PMCID: PMC3488462  NIHMSID: NIHMS414958  PMID: 23027005

Abstract

Laser scanning cytometer (LSC) is the microscope-based cytofluorometer that offers a plethora of unique analytical capabilities, not provided by flow cytometry (FCM). This review describes attributes of LSC and covers its numerous applications derived from plentitude of the parameters that can be measured. Among many LSC applications the following are emphasized: (a) assessment of chromatin condensation to identify mitotic, apoptotic cells, or senescent cells; (b) detection of nuclear or mitochondrial translocation of critical factors such as NF-κB, p53, or Bax; (c) semi-automatic scoring of micronuclei in mutagenicity assays; (d) analysis of fluorescence in situ hybridization (FISH) and use of the FISH analysis attribute to measure other punctuate fluorescence patterns such as γH2AX foci or receptor clustering; (e) enumeration and morphometry of nucleoli and other cell organelles; (f) analysis of progeny of individual cells in clonogenicity assay; (g) cell immunophenotyping; (h) imaging, visual examination, or sequential analysis using different probes of the same cells upon their relocation; (i) in situ enzyme kinetics, drug uptake, and other time-resolved processes; (j) analysis of tissue section architecture using fluorescent and chromogenic probes; (k) application for hypocellular samples (needle aspirate, spinal fluid, etc.); and (l) other clinical applications. Advantages and limitations of LSC are discussed and compared with FCM.

Keywords: Cytometry, Fluorescence, Cell cycle, Apoptosis, Nucleus, Nucleolus, Micronucleus, Cytoplasm, Enzyme kinetics

1. Introduction: Limitations of Flow Cytometry

During the past four decades, flow cytometry (FCM) has become commonplace in various disciplines of biology, medicine, and biotechnology. However, because cells are measured while suspended in a stream of liquid and subsequently discarded the analytical capability of FCM is limited for such applications as:

  1. The time-resolved events such as enzyme kinetics, drug uptake or efflux, cannot be analyzed in individual cells

  2. Morphology of the measured cell may only be assessed after sorting, which is cumbersome and not always available

  3. Subcellular localization of the fluorochrome cannot be analyzed

  4. The cell, once measured, cannot be reanalyzed with another probe(s)

  5. Analysis of solid tissue requires cell or nucleus isolation that leads to loss of information on tissue architecture

  6. Small-sized samples, such as fine needle aspirates or spinal fluid, are seldom analyzed by FCM because repeated sample centrifugations, that often are required, lead to cell loss

  7. The sample once measured is lost and cannot be stored for archival preservation

The microscope-based laser scanning cytometer (LSC), designed by Kamentsky (13) and manufactured since the mid 1990s by CompuCyte Corp. (Westwood, MA), offers many of the advantages of FCM, but does not have the limitations listed above. The analytical capabilities of LSC complement those of FCM and extend the use of cytometry in numerous research and clinical applications (for reviews see refs. (415)). This chapter is primarily focused on the capabilities of LSC and its applications that are either unique to this instrumentation or provide some advantages, vis-à-vis FCM, and updates our previous reviews (4, 14). The most comprehensive recent review of the hardware and software of LSC, focused primarily on the new iGeneration of LSC, is by Henriksen et al. (15).

2. Features of LSC and Parameters That Can Be Measured

The microscope (Olympus Optical Co.) is the key component of the instrument and provides essential structural and optical components (Fig. 1). The fluorescence excitation laser beams from up to four lasers, spatially merged by dichroic mirrors, are directed onto the computer-controlled oscillating (350 Hz) mirror which reflects them through the epi-illumination port of the microscope and images through the objective lens onto the slide. The mirror oscillations cause the laser beams to sweep the area of microscope slide under the lens. The beam spot size varies depending on the lens magnification, from 2.5 µm (at ×40) to 10.0 µm (at ×10). The slide, with its xy position monitored by sensors, is placed on the computer-controlled motorized microscope stage which moves at 0.5 µm steps per each laser scan, perpendicularly to the scan. Laser light scattered by the cells is imaged by the condenser lens and its intensity recorded by sensors. The specimen-emitted fluorescence is collected by the objective lens and directed to the scanning mirror. Upon reflection, it passes through a series of dichroic mirrors and optical emission filters to reach one of the four photomultipliers. Each photomultipler records fluorescence at a specific wavelength range, defined by the combination of filters and dichroic mirrors. A light source, additional to the lasers, provides transmitted illumination to visualize the objects through an eyepiece or the charge-coupling device (CCD) camera.

Fig. 1.

Fig. 1

Schematic representation of the laser scanning cytometer (LSC) (see text for explanation). It should be noted that the most recent models of LSC (iGeneration) have an inverted format with the laser illumination originating beneath the microscope slide (see ref. (15)).

The measurement of cell fluorescence (or light scatter) is computer-controlled and triggered by a threshold contour set above background (Fig. 2). The following parameters are recorded by LSC for each measured cell/object:

  1. Integrated fluorescence intensity, representing the sum of intensities of all pixels (“picture elements”) within the integration contour area. The latter may be adjusted to a desired width with respect to the threshold contour (Fig. 2)

  2. The maximal intensity of an individual pixel within this area (maximal pixel; “max pixel”)

  3. The integration area, representing the number of pixels within the integration contour

  4. The perimeter of the integration contour (in µm)

  5. Circularity, a measure of “roundness” calculated as the ratio of (perimeter2)/area

  6. The fluorescence intensity integrated over the area of a torus of desired width defined by the peripheral contour located around (outside) of the primary integration contour. For example, if the integration contour is set for the nucleus, based on red fluorescence (DNA stained by propidium iodide, PI), then the integrated (or maximal pixel) green fluorescence of fluorescein isothiocyanate (FITC)-stained cytoplasm can be measured separately, within the integration contour (i.e., over the nucleus) and within the peripheral contour, i.e., over the rim of cytoplasm of desired width outside the nucleus. All above values of fluorescence (a, b, d) are automatically corrected for background, which is measured outside the cell, within the background contour (Fig. 2)

  7. The xy coordinates of maximal pixel locating the measured object on the microscope stage

  8. The computer clock time at the moment of measurement

Fig. 2.

Fig. 2

Different settings for analysis of nuclear, total, and/or cytoplasmic fluorescence by LSC. When nuclear DNA is stained with a red fluorescing dye (e.g., propidium), the threshold contour (T) is set on red signal to detect the nucleus, e.g., as shown in (a). The integration contour (I) is then set a few pixels outside of T to ensure that all nuclear fluorescence is measured and integrated (a). However, when cytoplasmic fluorescence also is measured, I is set far away from T to ensure that fluorescence emitted from the cytoplasm is integrated as well (b). It also is possible to separately measure nuclear and cytoplasmic fluorescence as shown in (c). The peripheral contours (P) are then set at the desired number of pixels outside of I and the fluorescence intensities emitted from both areas, namely within the I boundary and within the P torus, are separately measured and separately integrated. In each case the background contour (B) is automatically set outside the cell and the background fluorescence is subtracted from nuclear, cytoplasmic, or total cell fluorescence. The actual cell’s contours, as they appear on the monitor, are shown in (D).

The software of LSC (WinCyte) allows one to obtain ratios of the respective parameters as a new parameter, and the ratiometric data can be displayed during data analysis. The electronic compensation of fluorescence emission spectra overlap is one of the features of the data analysis. The compensation at the time of data analysis is more convenient than in real-time, as it is in most flow cytometers, because it provides an opportunity to test and compare different settings for optimal results.

In addition to the parameters listed above, the WinCyte software of LSC is also designed to analyze the fluorescence in situ hybridization (FISH). Towards this end, the software allows one to establish, within a primary contour representing nucleus stained with a particular dye (e.g., propidium), a second set of contours representing another color (e.g., FITC) fluorescence. Five secondary features are then measured in addition to the major features that were listed above, namely: (a) number of secondary contours (i.e., FISH spots); (b) distance between the nearest spots; (c) integrated- and (d) maximal pixel-fluorescence, as well as (e) fluorescence area. The three last parameters (c–e) are measured for each secondary contour.

Recent advancements in development of LSC are represented by the iGeneration instruments (15). In these instruments (e.g., iCys® Research Imaging Cytometer), the beams from up to four lasers (with the six available excitation wavelengths at 405, 488, 532, 561, 594, and 633 nm) are combined into a coincident path and directed to an inverted microscope and onto a focal plane at the specimen. Thus, compared with most instruments that still are in use (schematically illustrated in Fig. 1), the laser illumination in the iGeneration LSCs is beneath the sample. The inverted format allows analysis of specimens on a variety of platforms, including microscope slides, microtiter plates, chamber slides, Petri dishes, or user-defined carriers fitting the footprint of a microtiter plate. Autofocus is integral to iGeneration cytometers, minimizing operator involvement during measurements. The available objectives are ×4, ×10, ×20, ×40, and ×60, offering nominal scan resolution (square pixels) of 2.5, 1.0, 0.5, 0.25, and 0.15 µm. The higher resolution imaging eliminates the need for additional imaging with an optical microscope and allows for post-scan visualization of any site of interest. In addition to fluorescence intensity, the laser light-loss (for use with chromatic dyes) can be measured by collecting the transmitted laser light and directing it to photodiode detectors. An optional robotic arm is available for large-scale walk-away experiments, allowing automatic loading of up to 45 carriers.

Moreover, the iGeneration software has also been upgraded. The raw scan data can be saved as JPEG or 16-bit image files suitable for data processing, specimen visualization, and quantification by proprietary analytical software. Contours can be generated around cellular events based on the fluorescence intensity, forward scatter, or light absorption, either automatically to select an entire sample area, or user-defined to target specific types of events. Scan images may be assembled into tiled mosaic images, allowing contours to be drawn on tissue sections, cell colonies, and other large events that span multiple scan fields. Once the contours are generated, the software can perform a wide range of analyses and produce output in the form of numerical statistics, scattergrams, histograms, expression maps, or other statistical visualizations. Special mathematical operations allow correction for spectral overlap and tissue auto fluorescence and permit combining different time-lapse images. Analysis protocols are easily “written” by graphically assembling various functional modules to establish the desired analytical work flow. Each module’s attributes can be easily modified, and the effect of these changes can be viewed immediately in the scanned images. Customizable protocol templates are provided as frameworks for different assays. More detailed and up-to-date description of the iGeneration LSC instruments is presented by Henriksen et al. (15).

The measurements by LSC are relatively rapid; for instance, with optimal cell density on the slide, up to 5,000 cells can be measured per minute. The accuracy and sensitivity of cell fluorescence measurements by LSC are comparable to the advanced flow cytometers (13).

Other methodologies that can quantify cell constituents measuring fluorescence, in addition to LSC and FCM, are fluorescence image analysis (FIA) and ImageStream cytometry (16). In FIA the cell illumination is uniform, provided by a mercury or xenon arc epi-illuminator. A band-pass filter selects fluorescence of a desired wavelength that is imaged at low depth of focus by a CCD camera. Compared with LSC or FCM that utilize photomultipliers, the dynamic range of sensitivity of fluorescence intensity measurement by a CCD is lower in FIA; thus, FIA cannot provide quantitative analysis of fluorescence intensity that would be on the par with FCM or LSC. ImageStream cytometry offers more rapid (up to 1,000 cells/s) analysis of individual cells compared to LSC. However, because unlike in LSC the interrogated cells are suspended in liquid rather than spread flat (stretched out) on slide, the spatial image resolution is inferior. Also, each cell can be measured only once in flow which prevents their repeated measurements, subsequent analysis by other probes, or archival preservation (16).

3. Maximal Pixel of Fluorescence Intensity

Maximal pixel of fluorescence intensity (MP) is a useful reporter of local hypo- or hyperchromicity, reflecting the degree of concentration (density) of the fluorescent probe either in intracellular compartments or on cell surfaces (e.g., receptor clustering). One of the early applications of LSC along this line was to identify cells with condensed chromatin. Specifically, because DNA in condensed chromatin, such as of mitotic or apoptotic cells, shows increased staining intensity (per unit area of chromatin image, because the same amount of DNA is compacted at higher spatial density), the MP of these cells stained with a DNA fluorochrome is higher than that of cells with the same DNA content but with diffuse chromatin (17, 18). Although mitotic cells can be recognized by cytometry using a variety of markers (reviewed in ref. (19)), an advantage of the MP marker is the use of a single fluorochrome to distinguish G1 vs. S vs. G2 vs. M phase cells. This enables one to apply another color fluorochrome(s) to detect other cell constituents. Such an approach has been used to combine pulse labeling of DNA replicating cells with bromodeoxyuridine (BrdU) (detected with anti-BrdU Ab) with identification of mitotic cells to study cell cycle kinetics by the “fraction of labeled mitoses” (FLM) method (20). The FLM assay, designed initially for tritiated thymidine autoradiography, yields a wealth of information on cell cycle kinetics, but in its original version (21) is cumbersome and time consuming. Its adaptation to LSC simplifies the procedure and shortens the time of analysis (20). Similar to mitotic-, BrdU-labeled meioticchromosomes were identified by LSC in studies of mutagenesis (22).

Apoptotic cells having condensed chromatin also can be identified by MP of DNA-associated fluorescence (14, 23, 24). It should be cautioned, however, that because mitotic and apoptotic cells both are characterized by high value of MPFI, the distinction of apoptotic—from mitotic—cells is not always possible. This limitation is of particular importance when apoptosis is induced by agents that arrest cells in mitosis, and therefore the sample contains mitotic cells that die by apoptosis (“mitotic catastrophe”). MP has also been found useful to detect localized caspase activity in early apoptotic cells by the analysis of local intracellular accumulation of the caspase-cleavage product of the fluorogenic substrate (25). Likewise, translocation of Bax to, and its accumulation in mitochondria, the event that facilitates the release of cytochrome c and activation of caspases was detected by LSC as an increase in MP of Bax immunofluorescence (26). The MP of DNA-associated fluorescence combined with fluorescence area, the parameter that reflects nuclear size and correlates inversely with chromatin condensation, was used to distinguish lymphocytes from monocytes and from granulocytes, the cell types that differ by the degree of chromatin condensation (27).

The utility of MP of the DNA-bound fluorochrome as measured by LSC was recently underscored in an analysis of cell senescence (28). The attribute of senescent cells is their morphology: enlargement and characteristic “flattening” of the nucleus (Fig. 3). When analyzed by LSC, this was reflected by an increase in nuclear area and a decline in intensity of MP, most pronounced as the decrease of the ratio of MP/nuclear area, providing a very sensitive biomarker of the degree of cell senescence (28). Still another utility of MP analysis by LSC was recently demonstrated by detection of the very early step of DNA damage response (DDR), namely recruitment of the MRN complex of proteins (Mre11, Rad50, Nbs1) to the DNA damage site (13). This event, which is essential for activation of Ataxia Telangiectasia mutated protein kinase (ATM) and initiation of the subsequent steps of DDR, was revealed as the increase in intensity of MP of Mre11 immunofluorescence measured over nuclei of cells subjected to oxidative stress (13, 29).

Fig. 3.

Fig. 3

Discrimination of cells undergoing senescence based on morphometric analysis of nuclear changes revealed by a decrease in intensity of maximal pixel of DNA-associated (DAPI) fluorescence and an increase in nuclear area. To induce senescence, A549 cells were treated in culture with DNA topoisomerase II inhibitor mitoxantrone (Mxt) for 48 h (b) or 72 h (c). Intensity of maximal (max) pixel of DNA/DAPI fluorescence reports the degree of chromatin condensation, and in untreated cells (a) has the highest value and marks mitotic (M) and immediately postmitotic (pM) cells. In the senescing cells, due to their extreme “fattening,” nuclear area increases and the intensity of maximal pixel decreases. The ratio of maximal pixel to nuclear area provides a sensitive marker of “depth” of cell senescence. Right panels show expression of CDK inhibitor p21, known to be another marker of senescent cells, measured concurrently with DNA (28).

4. Nuclear vs. Cytoplasmic Localization of Fluorescence

Fluorochrome-stained DNA provides a good marker defining nuclear boundary. If another color fluorochrome is used to mark other cell constituents, LSC is then able to resolve and separately measure nuclear and cytoplasmic content of such constituents (Fig. 2; peripheral torus). This capability can be used to detect translocation of particular proteins from cytoplasm to nucleus, or vice versa, e.g., to monitor the traffic of signal transduction or activation molecules. A classical example of such a protein is nuclear factor kappa B (NF-κB). This ubiquitous factor is involved in regulation of diverse immune and inflammatory responses and also plays a role in control of cell growth and apoptosis (30). Activation of NF-κB was detected by an increase in its immunofluorescence measured over the nucleus, concomitant with a decrease in fluorescence over the cytoplasm, which was reflected by a large increase in the nuclear to cytoplasmic fluorescence ratio (see ref. (31); Fig. 4). One of the virtues of this assay is that NF-κB activation can be correlated with cell morphology, immunophenotype, or cell cycle position (31). The assay of NF- κB translocation by LSC has been found more sensitive than any of the four alternative methods (32). This application of LSC can be extended to monitor other transcription factors that upon activation undergo translocation to the nucleus, such as tumor suppressor p53 and specific signal transduction or cell cycle regulatory molecules. For example, the upregulation and translocation of p53 from cytoplasm to nucleus in response to DNA damage by topoisomerase I inhibitor camptothecin was detected and measured by LSC (33). The nuclear location of proliferating cell nuclear antigen (PCNA), detected immunocytochemically by LSC, provided a good discrimination of the proliferating potential in histopatological analysis of renal cell carcinoma (34).

Fig. 4.

Fig. 4

Changes in intensity of NF-κB immunofluorescence integrated over the cell nucleus (FN; a, c) and cytoplasm (FC; b, d) in U-937 histiomonocytic lymphoma cells, untreated (a, b) and treated for 1 h with 10 ng/mL TNF- α (c, d). Note the increase in FN after the treatment (e) and even more pronounced increase in the FN /FC ratio (f). Bars indicate FN /FC of the cells gated in G1, S, and G2 /M based on differences in their DNA content as shown in (a); striped bars, prior to TNF-α treatment, shaded bars, after the treatment (25).

It should be mentioned that in the case of asymmetrically shaped cells (e.g., fibroblasts, neurons) or cells with acentric position of the nucleus (e.g., muscle cells), the integration of fluorescence from the entire cytoplasm is problematic. Partial solution to the problem may involve trypsinization followed by cell deposition on slides by cytocentrifugation. The cells that grow asymmetrically on slides become then more spherical, with the nucleus centrally located.

5. The Micronucleus Assay and DNA Damage Signaling

The micronucleus assay is widely used to assess the chromosomal or mitotic spindle damage induced by ionizing radiation or mutagenic agents in vivo or in vitro. Because visual scoring of micronuclei is cumbersome, semi-automatic procedures that rely either on FCM or image analysis were developed. LSC was adapted for the analysis of micronucleation induced by genotoxic agents in vivo in mouse erythrocytes (35), as well as in vitro, in cultured cells (12, 36, 37). The ability of LSC to relocate micronuclei for visual examination was useful in confirming their identification. Multiparameter characterization of micronuclei that took into an account their DNA content and protein/DNA ratio (Fig. 5) made it possible to establish the gating parameters that excluded objects that were not micronuclei (36). The percentage of micronuclei assayed by LSC correlated well with that estimated visually by microscopy in published studies (36, 37). LSC, thus, can be used to obtain an unbiased estimate of the frequency of micronuclei more rapidly than by conventional examination of the preparations by microscopy. Furthermore, unlike FCM, LSC allows one to characterize individual cells with respect to frequency and DNA content of micronuclei residing in these cells, and furthermore can be applied to the cytokinesis-blocked (e.g., by cytocholasin B) micronuclei assay (36, 37). Assessment of DNA damage is another measure of genotocicity or can be used as a marker of cell death (apoptosis). LSC has found an application for this purpose as well, specifically, for measuring the extent of DNA degradation and electrophoretic mobility from individual cells in the “comet” (38) or “halo” (39) assays.

Fig. 5.

Fig. 5

Detection of micronuclei by LSC. To induce micronuclei, HL-60 cells were treated with mitomycin C, then cytocentrifuged, fixed, and stained with FITC and PI. Micronuclei (located on this scatterplot within the dashed-line gating window where they consist ~93% of all events) were identified by their low DNA content (PI fluorescence) ranging between 0.1 and 5% of that of the whole G1 nuclei and FITC/PI fluorescence ratio that was similar to that of the whole nuclei (30).

During the past 5 years, LSC has been extensively used in studies of DDR (12, 4045). In these studies, the DNA damage signaling was detected immunocytochemically using phospho-specific Abs reactive with activated members of the signaling pathways: histone H2AX phosphorylated on Ser139 (γH2AX), ATM phosphorylated on Ser1981, p53 phosphorylated on Ser15, and Chk2 phosphorylated on Thr68. The advantage of LSC in these studies stems from the possibility of cell imaging, which allows one to identify cells having punctate (foci) distribution of γH2AX, considered to be a marker of double-strand DNA breaks (46). The multiparameter analysis of DNA damage signaling of cells treated with a variety of genotoxic agents correlated with identification of the cell cycle phase and active DNA replication detected by the “click chemistry” provided a wealth of information on mechanisms of DDR involving activation of cell cycle checkpoints, induction of apoptosis, and recruitment of the repair machinery (12, 4045).

6. Applications of LSC Utilizing the Software Designed for FISH Analysis

6.1. FISH Analysis, Cytogenetic Studies

Semi-automated FISH analysis represents still another LSC application that is based on its capability to spatially resolve the distribution of fluorescent regions within the cell (2, 46, 47). As mentioned, the software developed for this application allows one to establish, within a primary contour representing, e.g., nucleus stained with a particular dye (e.g., propidium), a second set of contours representing another color (e.g., FITC) fluorescence. An obvious advantage of LSC over visual analysis of FISH is the unbiased selection of the measured cells and their semi-automated, rapid measurement. Furthermore, the analysis of the integrated fluorescence intensity of the secondary contours may yield information pertaining to the degree of amplification of particular genome sections. Thus, for example, Kobayashi et al. (48), using the dual-color FISH analysis by LSC revealed an increase in 20q13 chromosomal copy number in several breast cancer cases and correlated it with DNA ploidy and estrogen- or progesterone-receptor status. LSC has also found utility in studies employing comparative genomic hybridization (CGH) to reveal cytogenetic aberrations in several types of human cancer (4951), studies of DNA ploidy in sperm cells (52), or the analysis of HER2 amplification in breast cancer (53). It should be noted, however, that semi-automated FISH measurements by LSC are subject to potential traps and require high quality technical preparations (2, 43).

6.2. Analysis of Nucleoli and Protein Translocations Between Nucleoli and Nucleoplasm

The capacity of the LSC software originally designed for semi-automatic FISH analysis may be applied to other applications. One such application is the quantitative analysis of nucleoli and monitoring traffic of molecules between nucleoli and nucleoplasm (54, 55). A useful immunocytochemical marker of nucleoli is an Ab to the nucleolar protein nucleolin. Using this Ab, it was possible to estimate the size of individual nucleoli (area and circumference), number of nucleoli per nucleus, total nucleolar area per nucleus, as well as expression of nucleolin separately in nucleoli and nucleoplasm (55). All these parameters have been found to strongly correlate with the proliferative status and the cell cycle position of mitogenically stimulated lymphocytes (55). Most interesting, however, was the observation that abundance of nucleolin in nucleoplasm was maximal during the cell transition from G0 to G1 phase of the cycle, which corresponded to the maximal rate of rRNA synthesis and its accumulation within the cell. The translocation of nucleolin from nucleoplasm to nucleoli was observed at later stages of lymphocyte stimulation, when the cells were progressing through G1, S, and G2/M and when the rate of rRNA accumulation was decreased (55). Similar application of LSC revealed the cell cycle phase-associated nucleoplasm-nucleolar shuttling of cyclin E, which was defective in bladder cancer cells (54).

6.3. Progeny of Individual Cells/Clonogenicity Assay

Another application of LSC utilizing the FISH approach was demonstrated in the analysis of progeny (clones) of individual cells (56). In this application, cellular protein and DNA were stained with fluorochromes of different color while the product of tumor suppressor gene p53 or estrogen receptor was detected immunocytochemically, with still another color fluorescent dye. The threshold contour was set on protein-associated fluorescence which made it possible to analyze the whole cell colony as a single entity. This approach made it possible to measure a variety of attributes of the progeny of individual cells (phenotype of individual cell colonies), such as colony size (area, circumference, cell number per colony), DNA and protein content per colony, expression of p53 or estrogen (per colony, per cell, per unit of DNA or protein), colony heterogeneity, and cell cycle distribution of individual cells within colonies. Such multiparameter analysis provided a wealth of information and has been used to study mechanisms by which the cytotoxic RNase—onconase affected proliferative capacity of the cells, induced growth imbalance, and differentiation (56). Extensions of LSC may make this instrument applicable for automatic analysis of cloning efficiency and multiparameter analysis of cell colonies in soft agar. Such analyses may be useful in studies of mechanisms and effectiveness of antitumor drugs, in the field of carcinogenesis, and for the analysis of primary cultures, including assessing tumor prognosis and drug sensitivity. The assay can also be adapted to the analysis of microbial colonies.

7. Cell Immunophenotyping

LSC has been adapted to perform routine immunophenotyping. Multi-chamber microscope slides were developed which can be used to automatically screen cells against up to 36 antibodies on a single slide by LSC (5762). The chambers are filled with cell suspension by capillary action. In the absence of serum or other proteins in the suspension, the cells strongly attach to the floor of the chambers by electrostatic interactions (5760). Various antibody combinations are then introduced into the chambers, the cells are incubated in their presence for 30–60 min, and following the rinse, their fluorescence is measured. The rate of analysis is relatively fast, as it takes ~20 min to screen the cells distributed in 12 wells labeled with a panel of 36 antibodies (three antibodies at a time), measuring 3,000–5,000 cells/well (5760).

Although the rate of measurement by LSC is slower than FCM, and the lack of side (90° angle) light scatter analysis precludes discrimination of lymphocytes from monocytes and granulocytes, certain advantages of LSC may outweigh these deficiencies. Thus, LSC is preferred for hypocellular samples which cannot tolerate repeated centrifugations that lead to cell loss. It should be stressed that loss of cells during centrifugations, as required for FCM analysis, is not random but preferential to different cell types (27). LSC analysis is also economical, since small sample size reduces the cost of reagents (Abs) by over 80% compared to FCM (5760). Furthermore, the LSC provides the possibility to relocate immunophenotyped cells for additional analysis or archival preservation.

8. The Relocation Attribute

8.1. Visual Cell Examination: Imaging

Because the spatial xy position of the measured cell is recorded, its relocation for visual examination by microscopy or imaging is possible. This attribute is of importance in many applications. For instance, in the analysis of apoptosis cell morphology still remains the gold standard to identify this mode of cell death (13, 23). Using LSC, it was possible to discriminate between genuine apoptotic cells and “false positive” cells in peripheral blood and bone marrow of leukemic patients undergoing chemotherapy (13). The latter cells were monocytes/macrophages containing apoptotic bodies (probably ingested from the disintegrating apoptotic cells) in their cytoplasm. While both the genuine apoptotic cells and the “false positive” cells contained numerous DNA strand breaks and were indistinguishable by FCM, the analysis of their morphology by LSC allowed their positive identification (13). In another study, eosinophils were identified by LSC as “false positive” apoptotic cells due to their nonspecific labeling with fluorescein-conjugated reagents (63). LSC was also helpful in distinguishing apoptotic cells from cells infected by Human Granulocytic Erlichiosis (64). Based on these observations, as well as other findings, it was concluded that LSC is the instrument of choice for the analysis of apoptosis (13, 65).

Several other methods of identification of apoptotic cells, including recognition by the presence of DNA strand breaks, decreased mitochondrial transmembrane potential, cleavage of poly (ADP-ribose) polymerase, or fractional DNA content, have been successfully adapted to LSC (66, 67). LSC was used to measure activation of caspases during apoptosis by the method utilizing fluorochrome-labeled caspase inhibitors (FLICA) (68), as well as to detect segregation of RNA from DNA and their separate packaging into apoptotic bodies (69). In all these studies the possibility of cell relocation for visual assessment of apoptosis was a valuable feature of LSC.

8.2. Sequential Analysis of the Same Cells with Different Probes

LSC allows one to integrate the results of two or more measurements into a single file (the “ file-merge” feature). This attribute provides the means to measure the same cells more than once, using different settings or probes (70). For example, it is possible to set the integration contour first on the nucleus and subsequently on the entire cell. This approach enables one to separately measure particular constituents in the nucleus and in the entire cell. Such analysis has been applied to reveal translocation of cyclin B1, detected immunocytochemically, from cytoplasm to nucleus during mitosis (71).

Another application of the file-merge feature of LSC was used for the analysis of cellular DNA and double-stranded (ds) RNA (72). Cells were stained with propidium iodide (PI) and measured twice, prior to, and after incubation with RNase. The integrated value of PI intensity of individual cells during the first measurement was proportional to their DNA plus ds RNA content. The PI fluorescence intensity during the subsequent measurement was due to the dye interaction with DNA only. Thus, when the second measurement was subtracted from the first measurement, the difference (“Differential Fluorescence”; DF) represented the RNA-associated PI fluorescence only. DF was then used as a separate parameter that was recorded in list mode in the merged file. Cellular protein was also counterstained, but with a fluorochrome of another color of emission than PI. The multiparameter analysis of these data made it possible to correlate, within the same cells, the cellular ds RNA content with DNA content (cell cycle position) or with protein content (72). This approach, using DF as an additional, discrete parameter for bivariate or multivariate analysis, extends the application of LSC for bivariate or multivariate analysis of other cell constituents which may be differentially stained with fluorochromes displaying the same wavelength of emission.

Still another application of the file-merge and sequential cell staining was to study a correlation between the supravitally detected cell attributes such as mitochondrial transmembrane potential or induction of oxidative stress, with attributes requiring cell fixation to be detected, such as the presence of DNA strand breaks (73). This approach revealed that the loss of transmembrane potential during apoptosis could be transient and not correlated with the activation of caspases and DNA cleavage (74).

The merging attribute of LSC and sequential (iterative) immunostaining with four CD-phenotype markers has been also been used to characterize human peripheral blood leukocytes (75). In still another elegant approach, the same authors (76) used several fluorochrome pairs, each pair having dyes of different photostability. The sequential photobleaching by LSC lasers followed by fluorescence measurement allowed them to separately record the emission of both the photo-labile and photostable (AlexaFluor dyes) fluorochrome bound to the same cell. In a more recent study, the merging-photobleaching approach has been used to test the applicability of photostable NorthernLights fluorochromes (77).

8.3. Enzyme Kinetics and Other Time-Resolved Events

The time of cell measurement by LSC is recorded in the list mode file together with other measured parameters. The relocation feature, in turn, makes it possible to measure the same cell repeatedly. Unlike FCM, LSC provides the means to measure kinetic reactions within individual cells in large cell populations. Using the fluorogenic substrate di-(leucyl)-rhodamine 110, the kinetic activity of l-aminopeptidase was measured in several cell types by LSC ((78); Fig. 6). Also assayed was the rate of fluorescein di-acetate hydrolysis by esterases, as well as the rate of uptake of the lysosomo-trophic fluorochrome acridine orange (78). Several hundred cells per sample were measured with a time resolution of 10–60 s. The kinetic curves constructed for individual cells were matched with the respective cells; subsequently, the cells were stained with absorption dyes and following relocation using bright light illumination identified as monocytes, granulocytes, or lymphocytes (78). In a similar manner, the kinetics of dissociation of fluorochromes from nuclear DNA, induced by caffeine, was measured by LSC, and the dissociation plots were constructed (79).

Fig. 6.

Fig. 6

l-Aminopeptidase activity of white blood cells from human peripheral blood. Cells were attached electrostatically to a slide and incubated with the fluorogenic substrate of l-aminopeptidase (di-(leucyl)-rhodamine 110). Fluorescence of cells within a specified area of the slide was repeatedly measured and time-resolved changes in green fluorescence intensity of these cells were recorded for leukocytes, and their fluorescence was repeatedly measured. Integrated value of the cell green fluorescence, position on the slide (x vs. y coordinate), and the time of measurement were recorded in a list mode for each cell (78). The changes in fluorescence of all measured cells as a function of time are shown in (a). Five cells were selected from (a) and using the “merge” program the kinetic curves for each of these cells were constructed and plotted (b). The slides were then air dried, stained with Giemsa, and examined by light microscopy. Individual monocytes, granulocytes, and lymphocytes were identified as those that matched with their respective kinetic plots. The cells characterized by a high rate of di-(leucyl)-rhodamine 110 cleavage were predominantly monocytes, those characterized by a moderate rate of cleavage were granulocytes, and by a minimal rate were lymphocytes (b) (78).

Repeated scanning of the same cells causes fluorescence fading. The fading, which may be extensive when time intervals between scanning are short, imposes a limitation on time resolution of kinetic measurements. However, the fading rate as well as the fluorescence recovery rate can be measured in the same cells by LSC and results corrected appropriately (78).

9. LSC in Clinical Pathology

Cytometry still plays a relatively minor role in routine clinical pathology. However, by quantifying key attributes of selected cells in a specimen (tissue section or fine needle aspirate; FNA), cytometry can contribute useful prognostic information and help guide therapy. Because little cell loss occurs during sample preparation, LSC is particularly suitable for hypocellular specimens. FNA samples (80), sputum (81), bladder washes (82), neonatal blood samples (60), or paraffin blocks of different tissues (83), each provides adequate numbers of cells/nuclei for the analysis by LSC. LSC can also be used for the analysis of histologic sections. Areas of interest that may be a minor component of the whole section can be selected to exclude extraneous tissues from measurement (84). The specimens can be destained and re-stained (85) to measure additional attributes of the same cells; moreover, the relocation feature of LSC allows one to precisely identify each cell by its location on the slide. Numerous publications attest to the usefulness of LSC in the analysis of tissue sections, FNA samples, or touch preparations (9, 8695).

One of the drawbacks inherent in measuring constituents of cells in histologic sections is that most of the cells are transected at different levels. Thus, because only a fraction of a cell or nucleus, unknown in size, is assayed, such measurement provides no information about the quantity of the measured constituent per cell. However, a ratiometric analysis, relating the quantity of the measured nuclear constituent per unit of DNA, normalizes the data and allows for comparisons between sections of different thickness (91). Still to be worked out are the computer-assisted analytical methods that will be needed to fully exploit the information present in histologic sections. In the case of solid tumors, this includes the relationship between tumor cells and reactive host cells, stroma, proliferating vessels, etc.; and the distribution of proliferating vs. apoptotic cells within the tumor; the expression of growth factor receptors in tumor cells according to location and in relation to host cells and blood vessels; and the effect of drug therapies on the functional measurements of cells. The number of measurable features is increasing, providing new tools to characterize and monitor human tumors in ways not possible by conventional light microscopy.

10. Utility of LSC in Other Applications

The major assets of LSC are the relocation, file-merge, and morphometric/imaging capabilities. These attributes are essential in studies of time-resolved events, such as enzyme kinetics, transmembrane transport rates of drugs or metabolites, and other cell functions. Likewise, in situ association constants of fluorochrome-conjugated ligands with the respective receptors can easily be assessed for individual cells by LSC by repeatedly measuring ligand binding to the same cells as a function of increasing ligand concentrations. After archival preservation, the same cells may be subjected to further measurements with new probes and the results merged into a single file for multivariate analysis. The same cells may be sequentially studied, first when they are alive (e.g., surface immunophenotyped, subjected to functional assays for a particular organelle, oxidative metabolism, pH, enzyme kinetics, etc.) and then, following their fixation (e.g., probed for DNA content to assess DNA ploidy and/or cell cycle distribution, DNA replication, content of an intracellular constituent(s) that can be detected immunocytochemically, etc.). To obtain their cytogenetic profile, the cells can be subsequently probed by FISH or in situ polymerase chain reaction (PCR). The length of telomere sections of DNA can be conveniently estimated in situ by LSC using FISH telomere probes (95, 96). Conventional staining with absorption dyes followed by microscopy can further identify the measured cells and correlate their morphology with any of the measured parameters. If desired, a more sophisticated image analysis of the selected cells can follow. An attachment of LSC to an image analysis system (Kontron KS 100) through standard connections has been described (97). LSC can also be combined with a laser-capture microdissection instrument to obtain histologically homogenous cell populations, e.g., for cytogenetic analysis (98).

LSC has the potential to be used to analyze in situ cell–cell interactions; one such application, to detect platelet–endothelial cell interactions, has already been demonstrated (99). This assay may be a sensitive marker predictive of vascular thrombosis. Still another application is in assessment of factors that modulate the kinetics of the in vitro “wound healing” when cells growing as a monolayer are mechanically or thermally wounded and LSC is used to measure the wound closure and assess the proliferative and apoptotic parameters of cells flanking the wound edges (100). Similarly, the damage to monolayer cultures of human epithelial corneal cells by topical glaucoma medications (101) or sensitivity of primary cultures of laryngeal carcinoma cells to cisplatin (102) was recently assessed by LSC.

Applications of LSC were particularly extensive in recent years in several distinct areas along the basic, preclinical, and clinical studies. One such area involved investigations of pancreatic islands (103108). In these studies both the fluorescence intensity as well as light-loss (absorbance) were measured on tissue sections stained either with fluorochromes or chromogenic dyes to obtain maximal information on cells of interest. These investigations were aimed to optimize conditions of growth and insulin or glucagon secretion by β or α cells, respectively. The data provided useful information pertinent to preclinical programs focused on islet transplantation. Another area of recent extensive use of LSC was in detecting circulating tumor cells (109115). In most of these studies the circulating tumor cells from peripheral blood were initially enriched either by density gradient centrifugation, nucleopore filtration, or immunomagnetic separation, to be subsequently identified and enumerated by LSC. Compared with alternative methods of circulating tumor cells detection, such as various FCM approaches, RT-PCR, and qRT-PSR methodologies, LSC offered certain advantages (109). The most important virtue of LSC in this application is the possibility to visually confirm the presence of tumor cells on the recorded images, and when needed to ascertain that they are indeed tumor cells, and to reexamine the once measured sample using another marker(s). The possibility of additional examination of these tumor cells with new probes to characterize their molecular signature with respect to expression of markers whose identification can help in designing proper targeted therapy is of particular importance.

Assessment of cell cycle, DNA ploidy, and investigations on mechanisms of cell proliferation was still another area where the unique analytical capabilities of LSC were extensively used recently (116123). Particularly advantageous in these studies was the possibility of multiparametric analysis combined with morphometric evaluation of cells. This combination has been also invaluable in another area where LSC also found wide application, namely in necrobiology, in studies of cell death, especially by mode of apoptosis (23, 124130). Activation of caspases, Bax translocation to mitochondria, DNA fragmentation leading to TUNEL positivity, and other markers were used in these studies to identify apoptotic cells either in clinical FNAs (127), peripheral blood of leukemic patients (128), in tissue sections (108), or in vitro drug treated cell lines, and in studies exploring mechanisms of induction of cell death by antitumor drugs (124126, 130).

The unique capabilities of LSC that make it possible to analyze tissue sections in which cells are stained either with fluorochromes, absorption dyes, or with both at the same time contributed to another area of wide LSC application in recent years (131136): Mapping tissue sections with respect to localization of particular proliferation or metabolic markers and quantification of their expression yielded much information in different branches of cell physiology and in oncology that could not be obtained by other means.

Among the recently introduced technical improvements facilitating applications of LSC, one has to consider an automatic micro fluidic sample preparation system that markedly expands possibilities of immunophenotyping of samples having very low number of cells (137). Compared with the original approach developed by Clatch (5759), this micro fluidic device is an important advancement that allows one to semi-automatically analyze samples having minimal numbers of cells. The open-source software adaptation for the analysis of LSC generated data (138) is another recent upgrade of LSC capabilities. It also offers the possibility of comparing LSC data with other cytometric measurements.

Progress in research in fields of cell biology, biotechnology, and medicine is being driven by development on new instrumentation and new methodologies. It is quite evident, as summarized above, that the versatility of the analytical capabilities of LSC contributed to its wide application and progress in these fields. It is expected that this progress will continue, and further advances in development of this instrumentation will expand its application in the future.

Acknowledgement

Supported by NCI Grant CA 28704 and by Robert A. Welke Foundation for Cancer Research.

Abbreviations

Ab

Antibody

ATM

Ataxia Telangiectasia mutated protein kinase

BrdU

Bromodeoxyuridine

CCD

Charge-coupling device

CGH

Comparative genomic hybridization

DF

Differential fluorescence

FCM

Flow cytometry

FIA

Fluorescence image analysis

FISH

Fluorescence in situ hybridization

FITC

Fluorescein isothiocyanate

FLICA

Fluorochrome-labeled inhibitors of caspases

FLM

Fraction of labeled mitoses

FNA

Fine needle aspirate

GFP

Green Fluorescent Protein

LSC

Laser scanning cytometer

mAb

Monoclonal antibody

MP

Maximal pixel

NF-kB

Nuclear factor kappa B

PCNA

Proliferating Cell Nuclear Antigen

PCR

Polymerase chain reaction

PI

Propidium iodide

RT-PCR

Reverse transcription-polymerase chain reaction

References

  • 1.Kamentsky LA, Kamentsky LD. Microscope-based multiparameter laser scanning cytometer yielding data comparable to flow cytometry data. Cytometry. 1991;12:81–87. doi: 10.1002/cyto.990120502. [DOI] [PubMed] [Google Scholar]
  • 2.Kamentsky LA, Burger DE, Gershman RJ, Kamentsky LD, Luther E. Slide-based laser scanning cytometry. Acta Cytol. 1997;41:123–143. doi: 10.1159/000332315. [DOI] [PubMed] [Google Scholar]
  • 3.Kamentsky LA. Laser scanning cytometry. Methods Cell Biol. 2001;63:51–83. doi: 10.1016/s0091-679x(01)63007-3. [DOI] [PubMed] [Google Scholar]
  • 4.Darzynkiewicz Z, Bedner E, Li X, Gorczyca W, Melamed MR. Laser-scanning cytometry: a new instrumentation with many applications. Exp Cell Res. 1999;249:1–12. doi: 10.1006/excr.1999.4477. [DOI] [PubMed] [Google Scholar]
  • 5.Gerstner AO, Laffers W, Tarnok A. Clinical applications of slide-based cytometry—an update. J Biophotonics. 2009;2:463–469. doi: 10.1002/jbio.200910029. [DOI] [PubMed] [Google Scholar]
  • 6.Harnett MM. Laser scanning cytometry: understanding the immune system in situ. Nat Rev. 2007;7:897–904. doi: 10.1038/nri2188. [DOI] [PubMed] [Google Scholar]
  • 7.Peterson RA, Krull DL, Butler L. Applications of laser scanning cytometry in immunochemistry and routine histopathology. Toxicol Pathol. 2008;36:117–132. doi: 10.1177/0192623307312704. [DOI] [PubMed] [Google Scholar]
  • 8.Galbavy S, Kullifay P. Laser scanning cytometry (LSC) in pathology—a perspective tool for the future. Bratisl Lek Listy. 2008;109:3–7. [PubMed] [Google Scholar]
  • 9.Taatjes DJ, Wadsworth MP, Quinn AS, Rand JH, Bovill EG, Sobel BE. Imaging aspects of cardiovascular disease at the cell and molecular level. Histochem Cell Biol. 2008;130:235–245. doi: 10.1007/s00418-008-0444-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Taatjes DJ, Palmer C, Pantano C, Hoffmann SB, Cummins A, Mossman BT. Laser-based microscopic approaches: application to cell signaling in environmental lung disease. Biotechniques. 2001;31:880–894. doi: 10.2144/01314rv01. [DOI] [PubMed] [Google Scholar]
  • 11.Darzynkiewicz Z, Smolewski P, Holden E, Luther E, Henriksen M, François M, Leifert W, Fenech M. Laser scanning cytometry for automation of the micronucleus assay. Mutagenesis. 2011;26:153–161. doi: 10.1093/mutage/geq069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Darzynkiewicz Z, Traganos F, Zhao H, Halicka HD, Skommer J, Wlodkowic D. Analysis of individual molecular events of DNA damage response by flow and image-assisted cytometry. Methods Cell Biol. 2011;103:115–148. doi: 10.1016/B978-0-12-385493-3.00006-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bedner E, Li X, Gorczyca W, Melamed MR, Darzynkiewicz Z. Analysis of apoptosis by laser scanning cytometry. Cytometry. 1999;35:181–195. doi: 10.1002/(sici)1097-0320(19990301)35:3<181::aid-cyto1>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  • 14.Pozarowski P, Holden E, Darzynkiewicz Z. Laser scanning cytometry: principles and applications. Methods Mol Biol. 2006;319:165–192. doi: 10.1007/978-1-59259-993-6_8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Henriksen M, Miller B, Newmark J, Al-Kofahi Y, Holden E. Laser scanning cytometry and its applications: a pioneering technology in the field of quantitative imaging. Methods Cell Biol. 2011;102:161–205. doi: 10.1016/B978-0-12-374912-3.00007-9. [DOI] [PubMed] [Google Scholar]
  • 16.Zuba-Sarma EK, Ratajczak M. Analytical capabilities of the ImageStream cytometry. Methods Cell Biol. 2011;102:207–230. doi: 10.1016/B978-0-12-374912-3.00008-0. [DOI] [PubMed] [Google Scholar]
  • 17.Luther E, Kamentsky LA. Resolution of mitotic cells using laser scanning cytometry. Cytometry. 1996;23:272–278. doi: 10.1002/(SICI)1097-0320(19960401)23:4<272::AID-CYTO2>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  • 18.Kawasaki M, Sasaki K, Satoh T, Kurose A, Kamada T, Furuya T, Murakami T, Todoroki T. Laser scanning cytometry (LSC) allows detailed analysis of the cell cycle in PI stained human fibroblasts (TIG-7) Cell Prolif. 1997;30:139–147. doi: 10.1046/j.1365-2184.1997.00082.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Darzynkiewicz Z. There’s more than one way to skin a cat: another way to assess mitotic index by cytometry. Cytometry A. 2008;73:368–369. doi: 10.1002/cyto.a.20543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Gorczyca W, Melamed MR, Darzynkiewicz Z. Laser scanning cytometer (LSC) analysis of fraction of labeled mitoses (FLM) Cell Prolif. 1996;29:9–47. doi: 10.1111/j.1365-2184.1996.tb00969.x. [DOI] [PubMed] [Google Scholar]
  • 21.Quastler H, Sherman FG. Cell population kinetics in the intestinal epithelium of mouse. Exp Cell Res. 1959;24:420–438. doi: 10.1016/0014-4827(59)90063-1. [DOI] [PubMed] [Google Scholar]
  • 22.Schmid TE, Attia S, Baumargartner A, Nuesse M, Adler ID. Effect of chemicals on the duration of male meiosis in mice detected with laser scanning cytometry. Mutagenesis. 2001;16:339–343. doi: 10.1093/mutage/16.4.339. [DOI] [PubMed] [Google Scholar]
  • 23.Wlodkowic D, Skommer J, Darzynkiewicz Z. Cytometry in cell necrobiology revisited. Recent advances and new vistas. Cytometry A. 2010;77A:591–606. doi: 10.1002/cyto.a.20889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Furuya T, Kamada T, Murakami T, Kurose A, Sasaki K. Laser scanning cytometry allows detection of cell death with morphological features of apoptosis in cells stained with PI. Cytometry. 1997;29:173–177. [PubMed] [Google Scholar]
  • 25.Telford WG, Komoriya A, Packard BZ. Detection of localized caspase activity in early apoptotic cells by laser scanning cytometry. Cytometry. 2002;47:81–88. doi: 10.1002/cyto.10052. [DOI] [PubMed] [Google Scholar]
  • 26.Bedner E, Li X, Kunicki J, Darzynkiewicz Z. Translocation of Bax to mitochondria during apoptosis measured by laser scanning cytometry. Cytometry. 2000;41:83–88. [PubMed] [Google Scholar]
  • 27.Bedner E, Burfeind P, Gorczyca W, Melamed MR, Darzynkiewicz Z. Laser scanning cytometry distinguishes lymphocytes, monocytes and granulocytes by differences in their chromatin structure. Cytometry. 1997;29:191–196. [PubMed] [Google Scholar]
  • 28.Zhao H, Halicka HD, Jorgensen E, Traganos F, Darzynkiewicz Z. New biomarkers probing the depth of cell senescence assessed by laser scanning cytometry. Cytometry A. 2010;77A:999–1007. doi: 10.1002/cyto.a.20983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Zhao H, Traganos F, Albino AP, Darzynkiewicz Z. Oxidative stress induces cell cycle-dependent Mre11 recruitment, ATM and Chk2 activation and histone H2AX phosphorylation. Cell Cycle. 2008;7:1490–1495. doi: 10.4161/cc.7.10.5963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kim HJ, Hawke N, Baldwin AS. NF-κB and IKK as therapeutic targets in cancer. Cell Death Differ. 2006;13:738–747. doi: 10.1038/sj.cdd.4401877. [DOI] [PubMed] [Google Scholar]
  • 31.Deptala A, Bedner E, Gorczyca W, Darzynkiewicz Z. Activation of nuclear factor kappa B (NF-κB) assayed by laser scanning cytometry (LSC) Cytometry. 1998;33:376–382. doi: 10.1002/(sici)1097-0320(19981101)33:3<376::aid-cyto13>3.0.co;2-q. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mercie P, Belloc F, Biblou-Nabera C, Barthe C, Provost A, Renard M, Seigneur M, Bernard P, Marit G, Biosseau MR. Comparative methodologic study on NFκB activation in cultured endothelial cells. J Lab Clin Med. 2000;136:402–411. doi: 10.1067/mlc.2000.109754. [DOI] [PubMed] [Google Scholar]
  • 33.Deptala A, Li X, Bedner E, Cheng W, Traganos F, Darzynkiewicz Z. Differences in induction of p53, p21WAF1, and apoptosis in relation to cell cycle phase of MCF-7 cells treated with camptothecin. Int J Oncol. 1999;15:861–871. doi: 10.3892/ijo.15.5.861. [DOI] [PubMed] [Google Scholar]
  • 34.Kawamura K, Kobayashi Y, Tanaka T, Ikeda R, Fujikawa-Yamamoto K, Suzuki K. Intranuclear localization of proliferating cell nuclear antigen during the cell cycle in renal cell carcinoma. Anal Quant Cytol Histol. 2002;22:107–113. [PubMed] [Google Scholar]
  • 35.Styles JA, Clark H, Festing MFW, Rew DA. Automation of mouse micronucleus genotoxicity assay by laser scanning cytometry. Cytometry. 2001;44:153–155. doi: 10.1002/1097-0320(20010601)44:2<153::aid-cyto1095>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  • 36.Smolewski P, Ruan Q, Vellon L, Darzynkiewicz Z. The micronuclei assay by laser scanning cytometry. Cytometry. 2001;45:19–26. doi: 10.1002/1097-0320(20010901)45:1<19::aid-cyto1140>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  • 37.Leifert WR, Francois M, Thomas P, Luther E, Holden E, Fenech M. Automation of the buccal micronucleus assay using laser scanning cytometry. Methods Cell Biol. 2011;102:321–340. doi: 10.1016/B978-0-12-374912-3.00013-4. [DOI] [PubMed] [Google Scholar]
  • 38.Petersen AB, Gniadecki R, Wulf HC. Laser scanning cytometry for comet assay analysis. Cytometry. 2000;39:10–15. doi: 10.1002/(sici)1097-0320(20000101)39:1<10::aid-cyto3>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  • 39.Bacso Z, Eliason JF. Measurement of DNA damage associated with apoptosis by laser scanning cytometry. Cytometry. 2001;45:180–186. doi: 10.1002/1097-0320(20011101)45:3<180::aid-cyto1161>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  • 40.Tanaka T, Halicka HD, Huang X, Traganos F, Darzynkiewicz Z. Constitutive histone H2AX phosphorylation and ATM activation, the reporters of DNA damage by endogenous oxidants. Cell Cycle. 2006;5:1940–1945. doi: 10.4161/cc.5.17.3191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Tanaka T, Huang X, Halicka HD, Zhao H, Traganos F, Albino AP, Dai W, Darzynkiewicz Z. Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents. Cytometry A. 2007;71A:648–661. doi: 10.1002/cyto.a.20426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Zhao H, Tanaka T, Halicka HD, Traganos F, Zarebski M, Dobrucki J, Darzynkiewicz Z. Cytometric assessment of DNA damage by exogenous and endogenous oxidants reports the aging-related processes. Cytometry A. 2007;71A:905–914. doi: 10.1002/cyto.a.20469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Zhao H, Traganos F, Darzynkiewicz Z. Kinetics of histone H2AX phosphorylation and Chk2 activation in A549 cells treated with topotecan and mitoxantrone in relation to the cell cycle phase. Cytometry A. 2008;73A:480–489. doi: 10.1002/cyto.a.20574. [DOI] [PubMed] [Google Scholar]
  • 44.Zhao H, Traganos F, Darzynkiewicz Z. Kinetics of the UV-induced DNA damage response in relation to cell cycle phase. Correlation with DNA replication. Cytometry A. 2010;77A:285–293. doi: 10.1002/cyto.a.20839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Zhao H, Dobrucki J, Rybak P, Traganos F, Halicka HD, Darzynkiewicz Z. Induction of DNA damage signaling by oxidative stress in relation to DNA replication as detected using the “click chemistry”. Cytometry A. 2011;79:897–902. doi: 10.1002/cyto.a.21137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Sedelnikova OA, Rogakou EP, Panuytin IG, Bonner W. Quantitative detection of 125IUdr-induced DNA double-strand breaks with γ-H2AX antibody. Radiat Res. 2002;158:486–492. doi: 10.1667/0033-7587(2002)158[0486:qdoiid]2.0.co;2. [DOI] [PubMed] [Google Scholar]
  • 47.Kamentsky LA, Kamentsky LD, Fletcher JA, Kurose A, Sasaki K. Methods for automatic multiparameter analysis of fluorescence in situ hybridized specimens with laser scanning cytometer. Cytometry. 1997;27:117–125. doi: 10.1002/(sici)1097-0320(19970201)27:2<117::aid-cyto3>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  • 48.Kobayashi Y, Yesato K, Oga A, Sasaki K. Detection of 20q13 gain by dual-color FISH in breast cancers. Anticancer Res. 2002;20:531–535. [PubMed] [Google Scholar]
  • 49.Hashimoto Y, Oga A, Okami K, Imate Y, Yamashita Y, Sasaki K. Relationship between cytogenetic aberrations by CGH coupled with tissue microdissection and DNA ploidy by laser scanning cytometry in head and neck squamous cell carcinoma. Cytometry. 2002;40:161–166. [PubMed] [Google Scholar]
  • 50.Harada K, Nishizaki T, Ozaki S, Kubota H, Harada K, Okamura T, Ito H, Sasaki K. Cytogenetic alteration in pituitary adenomas detected by comparative genomic hybridization. Cancer Genet Cytogenet. 1999;112:38–41. doi: 10.1016/s0165-4608(98)00235-0. [DOI] [PubMed] [Google Scholar]
  • 51.Harada K, Nishizaki T, Kubota H, Harada K, Suzuki M, Sasaki K. Distinct primary central nervous system lymphoma defined by comparative genomic hybridization and laser scanning cytometry. Cancer Genet Cytogenet. 2001;125:147–150. doi: 10.1016/s0165-4608(00)00377-0. [DOI] [PubMed] [Google Scholar]
  • 52.Baumgartner A, Schmid TE, Maers HK, Adler ID, Tarnok A, Nuesse M. Automated evaluation of frequencies of aneuploid sperm by laser-scanning cytometry (LSC) Cytometry. 2001;44:156–160. [PubMed] [Google Scholar]
  • 53.Xiao Y, Gao X, Maragh S, Telford WG, Tona A. Cell lines as candidate reference materials for quality control of ERBB2 amplification and expression assays in breast cancer. Clin Chem. 2009;55:1307–1315. doi: 10.1373/clinchem.2008.120576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Juan G, Cordon-Cardo C. Intranuclear compartmentalization of cyclin E during the cell cycle: disruption of the nucleoplasm-nucleolar shuttling of cyclin E in bladder cancer. Cancer Res. 2001;61:1220–1226. [PubMed] [Google Scholar]
  • 55.Gorczyca W, Smolewski P, Ardelt B, Ita M, Melamed MR, Darzynkiewicz Z. Morphometry of nucleoli and expression of nucleolin analyzed by laser scanning cytometry in mitogenically stimulated lymphocytes. Cytometry. 2001;45:206–213. doi: 10.1002/1097-0320(20011101)45:3<206::aid-cyto1164>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  • 56.Bedner E, Ruan Q, Chen S, Kamentsky LA, Darzynkiewicz Z. Multiparameter analysis of progeny of individual cells by laser scanning cytometry. Cytometry. 2000;40:271–279. doi: 10.1002/1097-0320(20000801)40:4<271::aid-cyto3>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  • 57.Clatch RJ, Foreman JR, Walloch JL. Simplified immunophenotypic analysis by laser scanning cytometry. Cytometry. 1998;34:3–16. doi: 10.1002/(sici)1097-0320(19980215)34:1<3::aid-cyto2>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  • 58.Clatch RJ, Foreman JR. Five-color immunophenotyping plus DNA content analysis by laser scanning cytometry. Cytometry. 1998;34:36–38. [PubMed] [Google Scholar]
  • 59.Clatch RJ. Immunophenotyping of hematological malignancies by laser scanning cytometry. Methods Cell Biol. 2001;64:313–342. doi: 10.1016/s0091-679x(01)64020-2. [DOI] [PubMed] [Google Scholar]
  • 60.Gerstner A, Lafler W, Bootz F, Tarnok A. Immunophenotyping of peripheral blood by laser scanning cytometry. J Immunol Methods. 2000;246:175–185. doi: 10.1016/s0022-1759(00)00284-2. [DOI] [PubMed] [Google Scholar]
  • 61.Takahashi H, Ruiz P, Ricordi C, Miki A, Barker S, Tzakis A, Ichii H. In situ quantitative immunopro filing of regulatory T cells using laser scanning cytometry. Transplant Proc. 2009;41:238–239. doi: 10.1016/j.transproceed.2008.10.060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Al-Za’abi AM, Geddie WB, Boerner SL. Equivalence of laser scanning cytometric and flow cytometric immunophenotyping of lymphoid lesions in cytologic samples. Am J Clin Pathol. 2008;129:780–785. doi: 10.1309/5VTRREUJW9LADRGT. [DOI] [PubMed] [Google Scholar]
  • 63.Bedner E, Halicka HD, Cheng W, Salomon T, Deptala A, Gorczyca W, Melamed MR, Darzynkiewicz Z. High affinity binding of fluorescein isothiocyanate to eosinophils detected by laser scanning cytometry: a potential source of error in analysis of blood samples utilizing fluorescein conjugated reagents in flow cytometry. Cytometry. 1999;36:77–82. doi: 10.1002/(sici)1097-0320(19990501)36:1<77::aid-cyto10>3.3.co;2-6. [DOI] [PubMed] [Google Scholar]
  • 64.Bedner E, Burfeind P, Hsieh T-C, Wu JM, Augero-Rosenfeld M, Melamed MR, Horowitz HW, Wormser GP, Darzynkiewicz Z. Cell cycle effects and induction of apoptosis caused by infection of HL-60 cells with human granulocytic ehrlichiosis (HGE) pathogen measured by flow and laser scanning cytometry (LSC) Cytometry. 1998;33:47–55. [PubMed] [Google Scholar]
  • 65.Darzynkiewicz Z, Bedner E, Traganos F. Difficulties and pitfalls in analysis of apoptosis. Methods Cell Biol. 2001;63:527–546. doi: 10.1016/s0091-679x(01)63028-0. [DOI] [PubMed] [Google Scholar]
  • 66.Li X, Melamed MR, Darzynkiewicz Z. Detection of apoptosis and DNA replication by differential labeling of DNA strand breaks with fluorochromes of different color. Exp Cell Res. 1996;222:28–37. doi: 10.1006/excr.1996.0004. [DOI] [PubMed] [Google Scholar]
  • 67.Darzynkiewicz Z, Bedner E. Analysis of apoptotic cells by flow- and laser scanning-cytometry. Methods Enzymol. 2000;322:18–39. doi: 10.1016/s0076-6879(00)22005-3. [DOI] [PubMed] [Google Scholar]
  • 68.Smolewski P, Bedner E, Du L, Hsieh T-C, Wu JM, Phelps DJ, Darzynkiewicz Z. Detection of caspases activation by fluorochrome-labeled inhibitors: multiparameter analysis by laser scanning cytometry. Cytometry. 2001;44:73–82. doi: 10.1002/1097-0320(20010501)44:1<73::aid-cyto1084>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  • 69.Halicka HD, Bedner A, Darzynkiewicz Z. Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. Exp Cell Res. 2000;260:248–256. doi: 10.1006/excr.2000.5027. [DOI] [PubMed] [Google Scholar]
  • 70.Mittag A. Merging of data files in laser scanning cytometry—seeing is believing? Cytometry A. 2008;73A:880–883. doi: 10.1002/cyto.a.20626. [DOI] [PubMed] [Google Scholar]
  • 71.Kakino S, Sasaki K, Kurose A, Ito H. Intracellular localization of cyclin B1 during cell cycle in gliomas cells. Cytometry. 1996;24:49–54. doi: 10.1002/(SICI)1097-0320(19960501)24:1<49::AID-CYTO6>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  • 72.Smolewski P, Grabarek J, Kamentsky LA, Darzynkiewicz Z. Bivariate analysis of cellular DNA versus RNA content by laser scanning cytometry using the product of signal subtraction (differential fluorescence) as a separate parameter. Cytometry. 2001;45:73–78. doi: 10.1002/1097-0320(20010901)45:1<73::aid-cyto1146>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  • 73.Li X, Darzynkiewicz Z. The Schrödinger’s cat quandary in biology: integration of live cell functional assays with measurements of fixed cells in analysis of apoptosis. Exp Cell Res. 1999;249:404–412. doi: 10.1006/excr.1999.4525. [DOI] [PubMed] [Google Scholar]
  • 74.Li X, Du L, Darzynkiewicz Z. During apoptosis of HL-60 and U-937 cells caspases are activated independently of dissipation of mitochondrial electrochemical potential. Exp Cell Res. 2000;257:290–297. doi: 10.1006/excr.2000.4901. [DOI] [PubMed] [Google Scholar]
  • 75.Leffers W, Mittag A, Lenz D, Tarnok A, Gerstner AO. Iterative restaining as a pivotal tool for n-color immunophenotyping by slide-based cytometry. Cytometry A. 2006;69:127–130. doi: 10.1002/cyto.a.20216. [DOI] [PubMed] [Google Scholar]
  • 76.Mittag A, Lenz D, Bocsi J, Sack U, Gerstner AO, Tarnok A. Sequential photobleaching of fluorochrome for polychromatic slide-based cytometry. Cytometry A. 2006;69:139–141. doi: 10.1002/cyto.a.20227. [DOI] [PubMed] [Google Scholar]
  • 77.Wessels JT, Busse AC, Mahrt J, Hoffschulte B, Mueller GA, Tarnok A, Mittag A. NorthernLights in slide-based cytometry and microscopy. Cytometry A. 2010;77:420–428. doi: 10.1002/cyto.a.20863. [DOI] [PubMed] [Google Scholar]
  • 78.Bedner E, Melamed MR, Darzynkiewicz Z. Enzyme kinetic reactions and fluorochrome uptake rates measured in individual cells by laser scanning cytometry (LSC) Cytometry. 1998;33:1–9. doi: 10.1002/(sici)1097-0320(19980901)33:1<1::aid-cyto1>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  • 79.Bedner E, Du L, Traganos F, Darzynkiewicz Z. Caffeine dissociates complexes between DNA and intercalating dyes: application for bleaching fluorochrome-stained cells for their subsequent restaining and analysis by laser scanning cytometry. Cytometry. 2001;43:38–45. [PubMed] [Google Scholar]
  • 80.Clatch RJ, Walloch JL, Foreman JR, Kamentsky LA. Multiparameter analysis of DNA content and cytokeratin expression in breast carcinoma by laser scanning cytometry. Arch Pathol Lab Med. 1997;121:585–592. [PubMed] [Google Scholar]
  • 81.Woltmann G, Ward RJ, Symon FA, Rew DA, Pavord ID, Wardlaw AJ. Objective quantitative analysis of eosinophils and bronchial epithelial cells in induced sputum by laser scanning cytometry. Thorax. 1999;54:124–130. doi: 10.1136/thx.54.2.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Wojcik EM, Saraga SA, Jin JK, Hendricks JB. Application of laser scanning cytometry for evaluation of DNA ploidy in routine cytologic specimens. Diagn Cytopathol. 2001;24:200–205. doi: 10.1002/1097-0339(200103)24:3<200::aid-dc1041>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  • 83.Kamiya N, Yokose T, Kiyomatsu Y, Fahey MT, Kodama T, Mukai K. Assessment of DNA content in formalin-fixed, paraffin-embedded tissue of lung cancer by laser scanning cytometry. Pathol Int. 1999;49:695–701. doi: 10.1046/j.1440-1827.1999.00937.x. [DOI] [PubMed] [Google Scholar]
  • 84.Grace MJ, Xie L, Musco ML, Cui S, Gurnani M, DiGiacomo R, Chang A, Indelicato S, Syed J, Johnson R, Nielsen LL. The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies. Am J Pathol. 1999;155:1869–1878. doi: 10.1016/S0002-9440(10)65506-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Musco ML, Shijun C, Small D, Nodelman M, Sugarman B, Grace M. Comparison of flow cytometry and laser scanning cytometry for the intracellular evaluation of adenoviral infectivity and p53 protein expression in gene therapy. Cytometry. 1998;33:290–296. doi: 10.1002/(sici)1097-0320(19981101)33:3<290::aid-cyto2>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  • 86.Rew DA, Reeve LJ, Wilson GD. Comparison of flow and laser scanning cytometry for the assay of cell proliferation in human solid tumors. Cytometry. 1998;33:355–361. doi: 10.1002/(sici)1097-0320(19981101)33:3<355::aid-cyto10>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  • 87.Gorczyca W, Darzynkiewicz Z, Melamed MR. Laser scanning cytometry in pathology of solid tumors. A review. Acta Cytol. 1997;41:98–108. doi: 10.1159/000332313. [DOI] [PubMed] [Google Scholar]
  • 88.Gorczyca W, Sarode V, Melamed MR, Darzynkiewicz Z. Laser scanning cytometric analysis of cyclin B1 in primary human malignancies. Mod Pathol. 1997;10:457–462. [PubMed] [Google Scholar]
  • 89.Kawamura K, Tanaka T, Ikeda R, Fujikawa-Yamamoto K, Suzuki K. DNA ploidy analysis in urinary tract epithelial tumors by laser scanning cytometry. Anal Quant Cytol Histol. 2000;22:26–30. [PubMed] [Google Scholar]
  • 90.Gorczyca W, Bedner E, Burfeind P, Darzynkiewicz Z, Melamed MR. Analysis of apoptosis in solid tumors by laser scanning cytometry. Mod Pathol. 1998;11:1–7. [PubMed] [Google Scholar]
  • 91.Gorczyca W, Davidian M, Gherson J, Ashikari R, Darzynkiewicz Z, Melamed MR. Laser scanning cytometry quantification of estrogen receptors in breast cancer. Anal Quant Cytol Histol. 1999;20:470–476. [PubMed] [Google Scholar]
  • 92.Tsukazaki Y, Numa Y, Zhao S, Kawamoto K. Analysis of DNA-ploidy using laser scanning cytometer in brain tumors and its clinical application. Hum Cell. 2000;13:221–228. [PubMed] [Google Scholar]
  • 93.Gerstner AO, Machlitt J, Laffers W, Tarnok A, Bootz F. Analysis of minimal sample volumes from head and neck cancer by laser scanning cytometry. Onkologie. 2002;25:40–46. doi: 10.1159/000055201. [DOI] [PubMed] [Google Scholar]
  • 94.Bollman R, Torks R, Schmitz J, Bolman M, Mehes G. Determination of ploidy and steroid receptor status in breast cancer by laser scanning cytometry. Cytometry. 2002;50:210–215. doi: 10.1002/cyto.10093. [DOI] [PubMed] [Google Scholar]
  • 95.Kajstura J, Peroldi B, Leri A, Beltrami CA, Deptala A, Darzynkiewicz Z, Anversa P. Telomere shortening is an in vivo marker of myocyte replication and aging. Am J Pathol. 2000;156:813–819. doi: 10.1016/S0002-9440(10)64949-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Izumi H, Hara T, Oga A, Matsuda K, Sato Y, Naito K, Sasaki K. High telomerase activity correlates with the stabilities of genome and DNA ploidy in renal carcinoma. Neoplasia. 2002;4:103–111. doi: 10.1038/sj.neo.7900205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Woltmann G, Wardlaw AJ, Rew DA. Image analysis enhancement of the laser scanning cytometer. Cytometry. 1997;33:262–265. doi: 10.1002/(sici)1097-0320(19981101)33:3<362::aid-cyto11>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  • 98.Mora J, Cheung NK, Juan G, Illei P, Cheung I, Akram M, Chi S, Landai M, Cordon-Cardo C, Gerald WL. Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumor progenitor cell. Cancer Res. 2001;61:6892–6898. [PubMed] [Google Scholar]
  • 99.Claytor RB, Li JM, Furman MI, Garnette CS, Rohrer MJ, Barnard MR, Krueger LA, Frelinger AL, III, Michelson AD. Laser scanning cytometry: a novel method for the detection of platelet-endothelial cell adhesion. Cytometry. 2001;43:308–313. doi: 10.1002/1097-0320(20010401)43:4<308::aid-cyto1063>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  • 100.Haider AS, Grabarek J, Eng B, Pedraza P, Ferreri NR, Balazs EA, Darzynkiewicz Z. In vitro wound healing analyzed by laser scanning cytometry. Accelerated healing of epithelial cell monolayers in the presence of hyaluronate. Cytometry A. 2003;53A:1–8. doi: 10.1002/cyto.a.10032. [DOI] [PubMed] [Google Scholar]
  • 101.Pozarowska D, Pozarowski P, Darzynkiewicz Z. Cytometric assessment of cytostatic and cytotoxic effects of topical glaucoma medications on human epithelial corneal line cells. Cytometry B Clin Cytom. 2010;78B:130–137. doi: 10.1002/cyto.b.20493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Klatka J, Paduch R, Pozarowski P, Pietruszewska W, Kupisz K, Trojanowski P, Rolinski J. Application of primary cell cultures of laryngeal carcinoma and laser scanning cytometry in the evaluation of tumor reactivity to cisplatinum. Folia Histochem Cytochem. 2008;46:159–164. doi: 10.2478/v10042-008-0024-5. [DOI] [PubMed] [Google Scholar]
  • 103.Krull DL, Peterson RA. Preclinical applications of quantitative imaging cytometry to support drug discovery. Methods Cell Biol. 2011;102:291–308. doi: 10.1016/B978-0-12-374912-3.00011-0. [DOI] [PubMed] [Google Scholar]
  • 104.Ichhi H, Miki A, Yamamoto T, Molano RD, Barker S, Mita A, Rodriguez-Diaz R, Klein D, Pastori R, Alejandro R, Inverardi L, Pillegi A, Ricordi C. Characterization of pancreatic ductal cells in human islet preparations. Lab Invest. 2008;88:1167–1177. doi: 10.1038/labinvest.2008.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Ito T, Omori K, Rawson J, Todorov I, Asari S, Kuroda A, Shintaku J, Itakura S, Ferreri K, Kandeel F, Mullen Y. Improvement of canine islet yield by donor pancreas infusion with p38MAPK inhibitor. Transplantation. 2008;86:321–329. doi: 10.1097/TP.0b013e31817ef6c9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Idlesias I, Bantsi-Barnes K, Umeadi C, Brown L, Kandeel F, Al-Abdullah IH. Comprehensive analysis of human pancreatic islets using flow and laser scanning cytometry. Transplant Proc. 2008;40:351–354. doi: 10.1016/j.transproceed.2008.01.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Yamamoto T, Ricordi C, Mita A, Miki A, Sakuma Y, Molano RD, Fomoni A, Inverardi LA, Ichii H. beta-Cell specific cytoprotection by prolactin on human islets. Transplant Proc. 2008;40:382–383. doi: 10.1016/j.transproceed.2008.01.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Todorov I, Nair I, Avakian-Mansoorian A, Rawson J, Omori K, Ito T, Valiente L, Inglesias-Meza J, Orr C, Shiang KD, Ferreri K, Al-Abdullah IH, Mullen Y, Kandeel F. Quantitative assessment of β-cell apoptosis and cell composition of isolated, undisrupted human islets by laser scanning cytometry. Transplantation. 2010;90:836–842. doi: 10.1097/TP.0b013e3181f1db5d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Lowes LE, Goodale D, Keeney M, Allan AL. Image cytometry analysis of circulating tumor cells. Methods Cell Biol. 2011;202:261–290. doi: 10.1016/B978-0-12-374912-3.00010-9. [DOI] [PubMed] [Google Scholar]
  • 110.Sanislo L, Vertakova-Krakovska B, Kuliffay P, Brtko J, Galbava A, Galbavy S. Detection of circulating tumor cells in metastatic breast cancer patients. Endocr Regul. 2011;45:113–124. doi: 10.4149/endo_2011_03_113. [DOI] [PubMed] [Google Scholar]
  • 111.Tao M, Ma D, Li Y, Zhou C, Li Y, Zhang Y, Duan W, Xu X, Wang R, Wu L, Liu H. Clinical significance of circulating tumor cells in breast cancer patients. Breast Cancer Res Treat. 2011;129:247–254. doi: 10.1007/s10549-011-1512-4. [DOI] [PubMed] [Google Scholar]
  • 112.Stanislo L, Kuliffay P, Sedlak J, Kausitz J, Galbavy S. Advanced detection and measurement of cells on membrane from peripheral blood by laser scanning cytometry (LSC) in early stage breast cancer patients. Bratisl Lek Listy. 2010;111:13–19. [PubMed] [Google Scholar]
  • 113.Hehmann N, Wicklein D, Schumacher U, Müller R. Comparison of two techniques for the screening of human tumor cells in mouse blood: quantitative real-time polymerase chain reaction (qRT-PCR) versus laser scanning cytometry. Acta Histochem. 2010;112:489–496. doi: 10.1016/j.acthis.2009.05.004. [DOI] [PubMed] [Google Scholar]
  • 114.Goodale D, Phay C, Postenka CO, Keeney M, Allan AL. Characterization of tumor cell dissemination pattern in preclinical models of cancer metastasis using flow cytometry and laser scanning cytometry. Cytometry A. 2009;75:344–356. doi: 10.1002/cyto.a.20657. [DOI] [PubMed] [Google Scholar]
  • 115.Pachmann K, Camara O, Kavallaris A, Krauspe S, Malarski N, Gajda M, Kroll T, Jorke C, Hammer U, Attendorf-Hofmann A, Rabenstein C, Pachmann U, Runnebaum I, Hoffken K. Monitoring the response of circulating epithelial cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol. 2008;26:1208–1215. doi: 10.1200/JCO.2007.13.6523. [DOI] [PubMed] [Google Scholar]
  • 116.Stefan T, Jacobberger JW. Laser scanning cytometry of mitosis: state and stage analysis. Methods Cell Biol. 2011;102:141–372. doi: 10.1016/B978-0-12-374912-3.00014-6. [DOI] [PubMed] [Google Scholar]
  • 117.Jacobberger JW, Frisa PS, Sramkoski RM, Stefan T, Shults KE, Soni DV. A new biomarker for mitotic cells. Cytometry A. 2008;73:5–15. doi: 10.1002/cyto.a.20501. [DOI] [PubMed] [Google Scholar]
  • 118.Tsujioka T, Tochigi A, Kishimoto M, Kondo T, Tasaka T, Wada H, Sugihara T, Yoshida Y, Tohyama K. DNA ploidy and cell cycle analyses in bone marrow cells of patients with megaloblastic anemia using laser scanning cytometry. Cytometry B. 2008;74:104–109. doi: 10.1002/cyto.b.20389. [DOI] [PubMed] [Google Scholar]
  • 119.Schwock J, Geddie WR, Hedley DW. Analysis of hypoxia-inducible factor 1-alpha accumulation and cell cycle in geldanamycin-treated human cervical carcinoma cells by laser scanning cytometry. Cytometry A. 2008;68:59–70. doi: 10.1002/cyto.a.20192. [DOI] [PubMed] [Google Scholar]
  • 120.Ohshima S, Seyama A. Cellular aging and centrosome aberrations. Ann N Y Acad Sci. 2010;1197:106–117. doi: 10.1111/j.1749-6632.2009.05396.x. [DOI] [PubMed] [Google Scholar]
  • 121.Chakrraborty AA, Tansey WP. Inference of cell cycle-dependent proteolysis by laser scanning cytometry. Exp Cell Res. 2009;315:1772–1778. doi: 10.1016/j.yexcr.2009.01.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Kuliffay P, Sanislo L, Galbavy S. Chromatin texture, DNA index, and S-phase fraction in primary breast carcinoma cells analyzed by laser scanning cytometry. Bratisl Lek Listy. 2010;111:4–8. [PubMed] [Google Scholar]
  • 123.Ren Y, Yin H, Tian R, Cui L, Zhu Y, Lin W, Tang XD, Gui Y, Zheng XL. Different effects of epidermal growth factor on smooth muscle cells derived from human myometrium and from leiomyoma. Fertil Steril. 2011;96(4):1015–1020. doi: 10.1016/j.fertnstert.2011.07.004. [DOI] [PubMed] [Google Scholar]
  • 124.Holme AL, Yaday SK, Pervaiz S. Automated laser scanning cytometry: a powerful tool for multi-parameter analysis of drug-induced apoptosis. Cytometry A. 2007;71:80–88. doi: 10.1002/cyto.a.20362. [DOI] [PubMed] [Google Scholar]
  • 125.Bingham B, Kotnis S, McHendry-Rinde B, Shen R, Wood A, Kennedy JD. Laser scanning cytometry in the characterization of the proapoptotic effects of transiently transfected genes in cerebellar granule neurons. Cytometry A. 2006;9:1114–1122. doi: 10.1002/cyto.a.20327. [DOI] [PubMed] [Google Scholar]
  • 126.Rosner K, Kasprzak MF, Horenstein AC, Thurston HL, Abrams J, Kervin LY, Mehregan DA, Mehregan DR. Engineering a waste management enzyme to overcome cancer-resistance to apoptosis: adding DNase1 to the anti-cancer toolbox. Cancer Gene Ther. 2011;18:346–3457. doi: 10.1038/cgt.2010.84. [DOI] [PubMed] [Google Scholar]
  • 127.Zoog SJ, Ma CY, Kaplan-Lefko PJ, Hawkins JM, Zhou L, Pan Y, Hau CP, Friberg G, Herbst R, Hill J, Juan G. Measurement of conatumumab-induced apoptotic activity in tumors by fine needle aspirate sampling. Cytometry A. 2010;77:849–850. doi: 10.1002/cyto.a.20940. [DOI] [PubMed] [Google Scholar]
  • 128.Urasinski T, Urasinska E, Grabarek J, Fydryk J, Domagala W. Good early treatment response in childhood acute lymphoblastic leukemia is associated with Bax nuclear accumulation and PARP cleavage. Med Sci Monit. 2009;15:294–301. [PubMed] [Google Scholar]
  • 129.Kammerer BD, Kultz D. Prolonged apoptosis in mitochondria-rich cells of tilapia (Oreochromis mossabicus) exposed to elevated salinity. J Comp Physiol B. 2009;179:535–542. doi: 10.1007/s00360-008-0333-1. [DOI] [PubMed] [Google Scholar]
  • 130.Sobolewska A, Gajewska M, Zarzynska J, Galkowska B, Motyl T. IGF-I, EGF, sex steroids regulate autophagy in bovine mammary epithelial cells via the mTOR pathway. Eur J Cell Biol. 2009;88:117–130. doi: 10.1016/j.ejcb.2008.09.004. [DOI] [PubMed] [Google Scholar]
  • 131.Wijsman JA, Obert LA, Paulissen J, Garrido R, Toy KA, Dunstan BW. A practical method to determine the amount of tissue to analyze using laser scanning cytometry. Cytometry A. 2007;71:501–508. doi: 10.1002/cyto.a.20397. [DOI] [PubMed] [Google Scholar]
  • 132.Hao S, Zhao H, Darzynkiewicz Z, Battula S, Ferreri NR. Differential regulation of NFAT5 by NKCC2 isoforms in medullary thick ascending limb (mTAL) cells. Am J Physiol Renal Physiol. 2011;300:F966–F975. doi: 10.1152/ajprenal.00408.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Gosens R, Stelmack GL, Bos ST, Dueck G, Mutawe MM, Schaafsma D, Unruh H, Gerthoffer WT, Zaagsma J, Meurs H, Halayko AJ. Caveolin-1 is required for contractile phenotype expression by airway smooth muscle cells. J Cell Mol Med. 2011;15:2430–2442. doi: 10.1111/j.1582-4934.2010.01246.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Hjelmeland LM, Fujikawa A, Oltjen SL, Smit-McBride Z, Braunschweig D. Quantification of retinal pigment epithelial phenotypic variation using laser scanning cytometry. Mol Vis. 2010;16:1108–1121. [PMC free article] [PubMed] [Google Scholar]
  • 135.Friedman B, Schachtrup C, Tsai PS, Shih AY, Akassoglou K, Kleinfeld D, Lyden PD. Acute vascular disruption and aquaporin 4 loss after stroke. Stroke. 2009;40:2182–2190. doi: 10.1161/STROKEAHA.108.523720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136.Kawauchi S, Furuya T, Ikemoto K, Yamamoto S, Oka M, Sasaki K. DNA copy number aberrations associated with aneuploidy and chromosomal instability in breast cancer. Oncol Rep. 2010;24:875–883. doi: 10.3892/or.2010.875. [DOI] [PubMed] [Google Scholar]
  • 137.Wu E, Menon V, Geddie W, Sun Y. An automated micro fluidic sample preparation system for laser scanning cytometry. Biomed Microdevices. 2011;13:393–401. doi: 10.1007/s10544-010-9508-0. [DOI] [PubMed] [Google Scholar]
  • 138.Mittag A, Pinto FE, Endringer DC, Tarnok A, Lenz D. Cellular analysis by open-source software for affordable cytometry. Scanning. 2011;33:33–40. doi: 10.1002/sca.20220. [DOI] [PubMed] [Google Scholar]

RESOURCES